|
Earnings Per Share Diluted Numerator (Detail) (USD $)
In Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jul. 03, 2011
|
Jul. 04, 2010
|
Jul. 03, 2011
|
Jul. 04, 2010
|
|
| EPS Numerator-Diluted: | ||||
| Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions | $ 2,580 | $ 2,444 | $ 4,792 | $ 4,449 |
| Discontinued operations-net of tax | 30 | 31 | 40 | 52 |
| Net income attributable to Pfizer Inc. common shareholders and assumed conversions | $ 2,610 | $ 2,475 | $ 4,832 | $ 4,501 |
| X | ||||||||||
|
- Definition
Eps Numerator Diluted Abstract
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the parent which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net Income or Loss Available to Common Stockholders plus adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|